Publications
HER2-positive breast cancer in patients with BRCA1/2 pathogenic variants: Case series and literature review;
Munnangi, P, Niravath, PA, Chang, JC & Sun, K 2025, , Current Problems in Cancer: Case Reports, vol. 17, 100335. https://doi.org/10.1016/j.cpccr.2024.100335
Perme ICU Physical Therapy Competency: Development of an ICU Knowledge and Skills Assessment Tool;
Perme, CS, Damasceno, MS, Chandrashekar, R, Xu, J, Ratnani, I, Masud, F & Wilches-Luna, EC 2024, , Intensive and Critical Care Nursing, vol. 85, 103750. https://doi.org/10.1016/j.iccn.2024.103750
Outcomes of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation Utilizing Extended Criteria Donor Grafts;
Brombosz, EW, Hobeika, MJ, Kodali, S, Connor, AA, Saharia, A, Mobley, CM, Simon, CJ, Cheah, YL, Abdelrahim, M, Victor, III, DW, Graviss, EA, Nguyen, DT, Moore, LW & Ghobrial, RM 2024, , Transplantation Proceedings, vol. 56, no. 10, pp. 2203-2212. https://doi.org/10.1016/j.transproceed.2024.10.039
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;
Dogra, P, Shinglot, V, Ruiz-RamÃrez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, AO, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA & Wang, Z 2024, , Molecular Cancer, vol. 23, no. 1, 156. https://doi.org/10.1186/s12943-024-02060-5
Chapter 24 - Patient characteristics and evaluations prior to liver transplantation;
Abdelrahim, M, Alqahtani, A, Esmail, A & Al-Judaibi, B 2024, . in MA Abdelrahim (ed.), Transplant Oncology. Academic Press, pp. 277-293. https://doi.org/10.1016/B978-0-443-21901-6.00024-0
Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapy;
Kalim, M, Jing, R, Guo, W, Xing, H & Lu, Y 2024, , Cancer Letters, vol. 606, 217306. https://doi.org/10.1016/j.canlet.2024.217306
Chapter 18 - History of cancer and transplant clearance: Considerations prior to transplantation;
Esmail, A & Abdelrahim, M 2024, . in MA Abdelrahim (ed.), Transplant Oncology. Academic Press, pp. 215-228. https://doi.org/10.1016/B978-0-443-21901-6.00018-5
Insights from a multiscale framework on metabolic rate variation driving glioblastoma multiforme growth and invasion;
Amereh, M, Shojaei, S, Seyfoori, A, Walsh, T, Dogra, P, Cristini, V, Nadler, B & Akbari, M 2024, , Communications engineering, vol. 3, no. 1, 176, pp. 176. https://doi.org/10.1038/s44172-024-00319-9
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis;
Xian, M, Wang, Q, Xiao, L, Zhong, L, Xiong, W, Ye, L, Su, P, Zhang, C, Li, Y, Orlowski, RZ, Zhan, F, Ganguly, S, Zu, Y, Qian, J & Yi, Q 2024, , Nature Communications, vol. 15, no. 1, 5767. https://doi.org/10.1038/s41467-024-50073-x
Chapter 8 - Transplant oncology and immunotherapy: Immunotherapy and liver transplants;
Abdelrahim, M & Esmail, A 2024, . in MA Abdelrahim (ed.), Transplant Oncology. Academic Press, pp. 87-105. https://doi.org/10.1016/B978-0-443-21901-6.00008-2